PG

Procter & Gamble Company
D

PG

Arincen73/100B

Procter & Gamble Company free cash flow 1990–2027

Procter & Gamble Company's free cash flow in Q1 FY2027, the three months to 30 September 2026, was 4.40B USD, up 4.6% on the same quarter a year before. Procter & Gamble Company's free cash flow over the last twelve months was 15.34B USD, up 2.7% on the twelve months before. In fiscal year 2026 it was 15.15B USD, up 7.8% on the year before.

Last updated 5 Nov 2026 · Next report 21 Jan 2027

Free cash flow

Free cash flow · +2.3% a year over 10 yearsFree cash flow margin

Growth

Fiscal yearPeriod endingFree cash flowGrowthFree cash flow marginOperating cash flowCapital expenditureFree cash flow per share
TTM30 Sept 202615.34B+2.66%17.45%19.92B-4.58B6.35
FY202630 Jun 202615.15B+7.85%17.40%19.56B-4.41B6.25
FY202530 Jun 202514.05B-15.00%16.66%17.82B-3.77B5.72
FY202430 Jun 202416.52B+19.86%19.66%19.85B-3.32B6.68
FY202330 Jun 202313.79B+1.61%16.81%16.85B-3.06B5.55
FY202230 Jun 202213.57B-12.94%16.92%16.72B-3.16B5.34
FY202130 Jun 202115.58B+8.75%20.47%18.37B-2.79B5.99
FY202030 Jun 202014.33B+20.47%20.20%17.40B-3.07B5.46
FY201930 Jun 201911.90B+6.68%17.57%15.24B-3.35B4.68
FY201830 Jun 201811.15B+19.01%16.68%14.87B-3.72B4.20
FY201730 Jun 20179.37B-22.70%14.40%12.75B-3.38B3.42
FY201630 Jun 201612.12B+11.49%18.56%15.44B-3.31B4.26
FY201530 Jun 201510.87B+7.54%15.37%14.61B-3.74B3.77
FY201430 Jun 201410.11B-6.95%13.59%13.96B-3.85B3.48
FY201330 Jun 201310.87B+16.58%13.56%14.87B-4.01B3.71
FY201230 Jun 20129.32B-7.02%11.37%13.28B-3.96B3.17
FY201130 Jun 201110.02B-22.92%12.36%13.33B-3.31B3.34
FY201030 Jun 201013.01B+11.33%16.77%16.07B-3.07B4.20
FY200930 Jun 200911.68B-2.35%15.23%14.92B-3.24B3.70
FY200830 Jun 200811.96B+14.03%14.63%15.01B-3.05B3.61
FY200730 Jun 200710.49B+20.46%13.72%13.44B-2.95B3.09
FY200630 Jun 20068.71B+34.01%12.76%11.38B-2.67B2.65
FY200530 Jun 20056.50B-11.45%11.45%8.68B-2.18B2.37
FY200430 Jun 20047.34B+1.66%14.27%9.36B-2.02B2.63
FY200330 Jun 20037.22B+19.05%16.64%8.70B-1.48B2.58
FY200230 Jun 20026.06B+82.73%15.07%7.74B-1.68B2.16
FY200130 Jun 20013.32B+100.24%8.45%5.80B-2.49B1.18
FY200030 Jun 20001.66B-38.99%4.15%4.68B-3.02B0.61
FY199930 Jun 19992.72B+16.77%7.12%5.54B-2.83B0.99
FY199830 Jun 19982.33B-38.02%6.26%4.89B-2.56B0.75
FY199730 Jun 19973.75B+89.64%10.49%5.88B-2.13B1.25
FY199630 Jun 19961.98B+39.17%5.61%4.16B-2.18B0.66
FY199530 Jun 19951.42B-21.35%4.25%3.57B-2.15B0.48
FY199430 Jun 19941.81B+26.70%5.97%3.65B-1.84B0.62
FY199330 Jun 19931.43B+23.12%4.69%3.34B-1.91B0.52
FY199230 Jun 19921.16B+1,187.78%3.95%3.07B-1.91B0.40
FY199130 Jun 199190.00M-87.25%0.33%2.07B-1.98B0.03
FY199030 Jun 1990706.00M—2.93%2.01B-1.30B0.24

Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Stock buybacks,Cash flow

Common questions about Procter & Gamble Company's free cash flow

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.